Legal Representation
Attorney
Bruce W. Longbottom
USPTO Deadlines
Next Deadline
91 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
October 29, 2025
Extension Available
Until October 29, 2025
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 17, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Mar 15, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 14, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 14, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 14, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 29, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 3, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 3, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 14, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 1, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 29, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 29, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 29, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 29, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 25, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 28, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 5, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Scientific research and development; Scientific laboratory services, namely, providing shared wet laboratory facilities and shared laboratory apparatus and instruments for others; Laboratory research in the field of pharmaceuticals; Biological research; clinical research in the field of pharmaceuticals; medical research; Pharmaceutical Research laboratory services; Scientific research consulting; Providing information relating to scientific research in the fields of biochemistry and biotechnology; Research and development in the field of therapeutics
Additional Information
Design Mark
The mark consists of Lilly ExplorR&D in a stylized font in the color red.
Color Claim
The color(s) red is/are claimed as a feature of the mark.
Pseudo Mark
LILLY EXPLORE AND D
Classification
International Classes
042